Invesco Pharmaceuticals State Street ETFs: Which Is Better?
Two popular healthcare ETFs, PJP and XBI, offer very different paths to exposure. This guide breaks down the trade-of...
Compare Target Date versus Index options in 401(k) plans, highlighting cost, diversification, and adaptability. Learn which fund type best fits your retirement timeline.
25,660 articlesTwo popular healthcare ETFs, PJP and XBI, offer very different paths to exposure. This guide breaks down the trade-of...
A looming major social security deadline could reshape retirement planning. This article explains what it is, why it ...
California voters will decide this November on a one-time 5% wealth tax aimed at billionaires to shore up Medicaid fu...
Investors chase steady monthly cash without loading up on megacap tech. This piece explains how a Nasdaq-focused inco...
QYLD offers a headline 12% yield through its covered-call strategy, yet 10-year total returns lag the Nasdaq-100 and ...
SpaceX activists and market watchers are neck-deep in debate over a potential IPO that could fetch a multi-trillion-d...
Analysts lift Intel targets on AI-driven demand, sending shares higher. The move underscores optimism about data cent...
A once-dismissed Google-backed AI fund has closed a $220 million fifth fund, illustrating how the seeds of AI investi...
MTUM has surged on momentum bets early in July, but a rotation out of high-multiple growth could weigh on the fund. T...
A focused electrification ETF outperformed the S&P 500 in the first half of 2026, turning a $10,000 stake into about ...
BWET has surged on a geopolitically driven spike in tanker rates. The rally hinges on one event, and a calm could tri...
A prominent fund dumped its monday.com stake in a move that coincided with a steep stock decline. This article breaks...